Financials
- Market Capitalization 25.75 M
- Employee 14
- Founded 2008
- CEO Steven C. Quay
- Website www.atossatherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002NCD8C8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4491 | BYSI BeyondSpring, Inc. - Ordinary Shares | 0.67 USD | +4.69% | -6.94% | -44.63% | -61.71% | 27.55 M USD | ||
| 4495 | EVAX Evaxion A/S - American Depositary Share | 3.03 USD | -3.81% | -8.46% | +7.83% | -8.73% | 25.27 M USD | ||
| 4508 | GNTA Genenta Science S.p.A. - American Depositary Shares | 1.03 USD | +4.04% | -18.25% | -34.81% | -72.68% | 24.14 M USD | ||
| 4511 | TVRD Tvardi Therapeutics, Inc. - Common Stock | 1.81 USD | 0.00% | -2.69% | -26.42% | -49.72% | 24.14 M USD |